FDA Approves New Tuberculosis Drug

The Food and Drug Administration has approved the first new tuberculosis drug in more than four decades.

Johnson & Johnson's Sirturo is for use with older drugs to fight a hard-to-treat strain of tuberculosis that has not responded to other medications.

The FDA cautions that the drug carries risks of potentially deadly heart problems and should be prescribed carefully by doctors.


We encourage commenting on our stories to give you a chance to express your opinion. We rely upon the online community to report abuse. Repeat violators may be banned from posting comments. CLICK HERE for the witn.com guidelines for posting comments. powered by Disqus